Vertex Pharmaceuticals (VRTX)

Operating Cash Flow Growth

11.61%

TTM · Period ending:

VRTX logo

VRTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported11.61%
VRTX TTM Cash from Operations YoY % (-34.29% → 11.61%)
High-resolution chart · PNG

VRTX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vertex Pharmaceuticals Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-1,229.8913%
70.3566%
47.6604%
112.3147%
108.3861%
3.997%
-2.2508%
-117.6471%
-35.1449%
-78.836%
-230.8511%
-170.4545%
-113.9535%
45.5331%
76.6749%
76.2803%
62.7168%
-79.7927%
-151.875%
-70.9677%
-73.8693%
-19.1358%
-8.8435%
-2,270%
-637.8378%
-331.4286%
-270.9302%
131.25%
178.7234%
220.6897%
262.2642%
23.8095%
-34.2857%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.